-
-
-
-
-
-
-
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
-
-
-
-
-
-
-
Optimi Health ships psilocybin to UK for phase 2 clinical trial
-
-
-
-
-
-
-
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
-
-
-
-
-
-
-
Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
-
-
-
-
16,020 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

